FDA Modernization Act 3.0

Cost and committee reports

Official records Congress.gov attaches to H.R. 7248.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. CARTER of Georgia, as printed in the Congressional Record (Vol. 170, No. 21, February 6, 2024, Page H503):
  Article 1, Section 8 of the Constitution The single subject of this legislation is: To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.
  Source: Congress.gov, Congressional Record February 6, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  424 characters

  Congress.gov bill record

  H.R. 7248, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/7248

  Record last updated by Congress.gov

  May 27, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  dbf865d0d3e3c287bafd5cfb4136f8bb441f61ef6b0df9bb3ec4eab26d1fca44

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of May 27, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 7248, last updated May 27, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.